David Rhainds

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

Jean‐Claude Tardif, Simon Kouz, David D. Waters et al. · New England Journal of Medicine · 2019 · 3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

NARC-1/PCSK9 and Its Natural Mutants

Suzanne Benjannet, David Rhainds, Rachid Essalmani et al. · Journal of Biological Chemistry · 2004 · 625 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

The Proprotein Convertase (PC) PCSK9 Is Inactivated by Furin and/or PC5/6A

Suzanne Benjannet, David Rhainds, Josée Hamelin et al. · Journal of Biological Chemistry · 2006 · 272 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically

Jian Wang, Jacqueline S. Dron, Matthew R. Ban et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2016 · 208 citations

Medicine, Genetics, Molecular Genetics +16

Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib

Jean‐Claude Tardif, Éric Rhéaume, Louis‐Philippe Lemieux Perreault et al. · Circulation Cardiovascular Genetics · 2015 · 187 citations

Medicine, Genetics, Pharmacology +17